VIVENT HEALTH PARTNERS WITH ASPIRUS HEALTH FOUNDATION
VIVENT HEALTH PARTNERS WITH ASPIRUS HEALTH FOUNDATION TO PREVENT OPIOID OVERDOSE IN MARATHON COUNTY AND SURROUNDING COMMUNITIES
Grant awarded to fund Naloxone and Naloxone Administration Trainings
Milwaukee, WI – Vivent Health announced today its award of a $25,000 grant from Asprius Health Foundation to prevent opioid overdose in Marathon County, Wisconsin and surrounding communities. The funding will provide Nalaxone and trainings on how to administer Nalaxone to individuals at Vivent Health’s Wausau clinic as well as statewide through Naloxone administration and distribution programs.
“The Aspirus Health Foundation’s vision is to be the leader in developing community partnerships to advance the health of people in Northcentral Wisconsin,” says Tara Draeger, Aspirus System Community Health Improvement Director. “This grant is one of the many ways we’re turning our vision in to action.”
Naloxone — a life-saving medication that can reverse an overdose from opioids, including heroin, fentanyl, and prescription opioid medications — is distributed via LifePoint, Vivent Health’s nationally recognized drug overdose prevention program. The program also includes syringe access, harm reduction, Fentanyl test strip distribution and training programs.
“Our LifePoint program directly aligns with the Aspirus Health Foundation’s mission to develop critical resources necessary to advance the health of our communities and increase health services in the region,” said Margaret Lidstone, Chief Development Officer at Vivent Health. “Together, Aspirus Health Foundation and Vivent Health can ensure that people at-risk for opioid overdose have a champion to help them navigate the prevention, management, and treatment of opioid addiction.”